StockData
ADARx Pharmaceuticals, Inc. logo

ADARx Pharmaceuticals, Inc. (ADRX) stock

ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$12.82−1.00 (-7.24%)

Close on Nov 18, 2026Market cap $1.38BP/E –Yield –

ADARx Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for ADARx Pharmaceuticals

ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ADARx Pharmaceuticals figures

See a number that looks wrong?